Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...
Stacker on MSNOpinion
Common medications for high cholesterol
SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...
The long-running legal dispute between Amgen and Sanofi/Regeneron on two key patents covering the use of PCSK9 inhibitors to lower cholesterol has come to an end, with Sanofi emerging as the victor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback